Results
|
21.
|
|
|
22.
|
|
|
23.
|
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. [electronic resource] by
- Del Campo, J M
- Roszak, A
- Bidzinski, M
- Ciuleanu, T E
- Hogberg, T
- Wojtukiewicz, M Z
- Poveda, A
- Boman, K
- Westermann, A M
- Lebedinsky, C
Producer: 20100108
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
24.
|
|
|
25.
|
At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. [electronic resource] by
- Westermann, A M
- Holtkamp, M M
- Linthorst, G A
- van Leeuwen, L
- Willemse, E J
- van Dijk, W C
- Nooijen, W J
- Baars, J W
- Schornagel, J H
- Rodenhuis, S
Producer: 19990902
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 10
Availability: No items available.
|
|
26.
|
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. [electronic resource] by
- Westermann, A M
- Grosen, E A
- Katschinski, D M
- Jäger, D
- Rietbroek, R
- Schink, J C
- Tiggelaar, C L
- Jäger, E
- Zum Vörde sive Vörding, P
- Neuman, A
- Knuth, A
- Van Dijk, J D
- Wiedemann, G J
- Robins, H I
Producer: 20010712
In:
European journal of cancer (Oxford, England : 1990) vol. 37
Availability: No items available.
|
|
27.
|
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. [electronic resource] by
- Lybol, C
- Thomas, C M G
- Blanken, E A
- Sweep, F C G J
- Verheijen, R H
- Westermann, A M
- Boere, I A
- Reyners, A K L
- Massuger, L F A G
- van Hoesel, R Q G C M
- Ottevanger, P B
Producer: 20130409
In:
European journal of cancer (Oxford, England : 1990) vol. 49
Availability: No items available.
|
|
28.
|
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours. [electronic resource] by
- Leary, A F
- Quinn, M
- Fujiwara, K
- Coleman, R L
- Kohn, E
- Sugiyama, T
- Glasspool, R
- Ray-Coquard, I
- Colombo, N
- Bacon, M
- Zeimet, A
- Westermann, A
- Gomez-Garcia, E
- Provencher, D
- Welch, S
- Small, W
- Millan, D
- Okamoto, A
- Stuart, G
- Ochiai, K
Producer: 20170502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
29.
|
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. [electronic resource] by
- Westermann, A M
- Wiedemann, G J
- Jager, E
- Jager, D
- Katschinski, D M
- Knuth, A
- Vörde Sive Vörding, P Z
- Van Dijk, J D P
- Finet, J
- Neumann, A
- Longo, W
- Bakhshandeh, A
- Tiggelaar, C L
- Gillis, W
- Bailey, H
- Peters, S O
- Robins, H I
Producer: 20030604
In:
Oncology vol. 64
Availability: No items available.
|
|
30.
|
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. [electronic resource] by
- Hallek, M
- Fischer, K
- Fingerle-Rowson, G
- Fink, A M
- Busch, R
- Mayer, J
- Hensel, M
- Hopfinger, G
- Hess, G
- von Grünhagen, U
- Bergmann, M
- Catalano, J
- Zinzani, P L
- Caligaris-Cappio, F
- Seymour, J F
- Berrebi, A
- Jäger, U
- Cazin, B
- Trneny, M
- Westermann, A
- Wendtner, C M
- Eichhorst, B F
- Staib, P
- Bühler, A
- Winkler, D
- Zenz, T
- Böttcher, S
- Ritgen, M
- Mendila, M
- Kneba, M
- Döhner, H
- Stilgenbauer, S
Producer: 20101019
In:
Lancet (London, England) vol. 376
Availability: No items available.
|